Molecular Determinants of the Response of Glioblastomas to EGFR Kinase InhibitorsIngo K. Mellinghoff, Paul S. Mischel, Charles L. Sawyers et al.|New England Journal of Medicine|2005Cited by 1.4k
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingZachary A. Knight, Kevan M. Shokat, Beatriz González et al.|Cell|2006Cited by 1.2k
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaQi-Wen Fan, William A. Weiss, Zachary A. Knight et al.|Cancer Cell|2006Cited by 584
Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to ErlotinibDaphne A. Haas-Kogan, David Stokoe|JNCI Journal of the National Cancer Institute|2005Cited by 467
PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic TransformationKatsutoshi Oda, Frank McCormick, Jennifer Okada et al.|Cancer Research|2008Cited by 193